LKT Labs

Biochemicals for Life Science Research

Awaiting product image

Lomerizine Dihydrochloride

Product ID L5751
Cas No. 101477-54-7
Purity ≥98%
Product Unit SizeCostQuantityStock
100 mg $71.70 In stock
500 mg $115.80 In stock
1 g $193.00 In stock
5 g $578.90 In stock
Bulk Quote

Quicklinks

Description

Lomerizine is an inhibitor of voltage-gated L-type and T-type Ca2+ channels as well as transient receptor potential (TRP5) channels. Lomerizine is clinically used to treat migraine and vertigo. Lomerizine exhibits neuroprotective benefit in animal models of amyotrophic lateral sclerosis (ALS), decreasing glutamate excitotoxicity, Ca2+ overload, and mitochondrial dysfunction. In other animal models, lomerizine protects against NMDA-induced retinal damage and neurodegeneration. TEST!!!!!!

Product Info

Cas No.

101477-54-7
Purity

≥98%
Formula

C27H30F2N2O3 • 2HCl
Formula Wt.

541.47
Chemical Name

1-[Bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride
IUPAC Name

1-[bis(4-fluorophenyl)methyl]-4-[(2,3, 4-trimethoxyphenyl)methyl]piperazine;dihydrochloride
Synonym

Lomerizine dihydrochloride
Melting Point

204-207°C

Appearance

White or off-White Crystalline Powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

L5751 MSDS PDF
Info Sheet

L5751 Info Sheet PDF

References

Tran LT, Gentil BJ, Sullivan KE, et al. The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43. J Neurochem. 2014 Apr 9. [Epub ahead of print]. PMID: 24716897.

Inoue Y, Yabe T. Lomerizine therapy for the treatment of benign paroxysmal vertigo of childhood transitioning into atypical basilar migraine: A case report. Exp Ther Med. 2013 Jun;5(6):1573-1575. PMID: 23837033.

Ito Y, Nakamura S, Tanaka H, et al. Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice. CNS Neurosci Ther. 2010 Apr;16(2):103-14. PMID: 19788586.

Fitzgerald M, Bartlett CA, Harvey AR, Dunlop SA. Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study. J Neurotrauma. 2010 Feb;27(2):439-452. PMID: 19852581.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F1655

    Fenoprofen Calcium Dihydrate

    NSAID; COX-1/2 inhibitor.

    ≥97%
  • A761001

    AT-7519 free base

    ATP competitive CDK inhibitor.

    ≥98%
  • M1746

    Melphalan

    Nitrogen mustard, DNA alkylator.

    ≥94%
  • B5075

    BMS-708163

    γ-Secretase inhibitor.

    ≥98%
  • P7219

    Pseudolaric Acid B

    Diterpene acid found in Pseudolarix kaempferi.<...

    ≥98%
  • G7440

    GSK-1120212

    MEK1/2 inhibitor.

    ≥98%
  • F5770

    Formononetin

    Isoflavone found in legumes such as soy.

    ≥90%
  • B3203

    Biapenem

    β-lactam; penicillin binding protein inhibitor...

    ≥98%
  • B1898

    Bezafibrate

    Fibrate; PPARα agonist.

    ≥98%
  • A5284

    [Val5]-Angiotensin II, human

    Peptide, derivative of AT II, involved in vasoc...

    ≥95%
  • F8149

    Fumonisin B1

    Mycotoxin produced by Fusarium; sphingosine acy...

    ≥98%
  • A7577

    Astilbin

    Flavonoid found in various plant sources.

    ≥99%
  • G124080

    GDC-0994

    ERK1/2 inhibitor.

    ≥98%
  • B3458

    Biopterin

    Endogenous pterin coenzyme required for release...

    ≥98%
  • A4849

    Amyloid-β (25-35)

    Endogenous APP peptide cleavage product, primar...

    ≥95%
  • T3350

    Timolol Maleate

    β-adrenergic antagonist.

    ≥98%
  • L960008

    LY-3177833

    Cdc7 inhibitor.

    ≥99%
  • B030960

    BAY-1082439

    PI3K inhibitor.

    ≥98%
  • M0124

    Magainin 1

    Antimicrobial peptide found in frogs, induces p...

    ≥95%